News & Perspective

Dec 21, 2001

Dec 21, 2001

Congress approves $2.5 billion for bioterrorism preparedness

(CIDRAP News) – In a flurry of pre-adjournment activity yesterday, Congress appropriated about $2.5 billion for bioterrorism preparedness, including $1 billion for state and local efforts, according to an aide to Sen. Bill Frist, R-Tenn.

Dec 19, 2001

Dec 19, 2001

Anthrax vaccine to be offered to postal and Capitol workers

(CIDRAP News) – Because of a small theoretical risk that anthrax spores can hide in the lungs for up to 100 days and grow after antibiotic treatment is stopped, the anthrax vaccine and an extension of antibiotic treatment will be offered to people who may have been exposed in the recent anthrax attacks, federal health officials announced yesterday afternoon.

Dec 13, 2001

Dec 13, 2001

House passes $2.9 billion authorization for bioterrorism preparedness

(CIDRAP News) – The US House of Representatives on Wednesday overwhelmingly approved a bill authorizing about $2.9 billion in spending on preparedness for bioterrorism and other public health emergencies.

Dec 13, 2001

Dec 13, 2001

Finding an antitoxin is among priorities for anthrax research

(CIDRAP News) – The Centers for Disease Control and Prevention's (CDC's) priorities for research on anthrax include development of an antitoxin, aerosolization of anthrax powders sent by mail, and postexposure prophylaxis, CDC officials said this week.

Dec 07, 2001

Dec 07, 2001

Rapid tests for environmental anthrax should not be used alone, CDC says

(CIDRAP News) – Rapid tests for detecting anthrax spores on surfaces should not be used alone as the basis for public health or clinical decisions, the Centers for Disease Control and Prevention warned in today's issue of Morbidity and Mortality Weekly Report.

Nov 30, 2001

Nov 30, 2001

Ciprofloxacin side effects ranged up to 19% in postal workers

(CIDRAP News) – About 19% of more than 3,000 postal workers who took ciprofloxacin to prevent anthrax from the recent bioterrorist attacks reported having "severe" gastrointestinal side effects, but only 2% sought medical attention for them, according to the Centers for Disease Control and Prevention (CDC). Officials described the findings as being in line with other reports on ciprofloxacin.

Nov 30, 2001

Nov 30, 2001

Acambis wins new contract to supply 155 million doses of smallpox vaccine

Nov 29, 2001 (CIDRAP News) – The US Department of Health and Human Services (HHS) has awarded Acambis Inc. a $428 million contract to produce an additional 155 million doses of smallpox vaccine by the end of 2002, HHS Secretary Tommy G. Thompson announced Wednesday.

Nov 27, 2001

Nov 27, 2001

CDC smallpox plan favors focused vaccination program over mass campaign

(CIDRAP News) – If smallpox reappears in the United States, health authorities will strive to trace and vaccinate everyone who has had contact with infected or exposed persons but probably will not mount any mass vaccination campaigns, according to a draft plan released Monday by the Centers for Disease Control and Prevention (CDC).

Nov 22, 2001

Nov 22, 2001

Three deaths after knee surgery prompt CDC search for similar cases

Nov 21, 2001 (CIDRAP News)—A cluster of three unexplained deaths after routine knee surgeries in Minnesota has prompted the Centers for Disease Control and Prevention (CDC) to hunt for similar cases nationwide and caused Minnesota health officials to call a 1-week moratorium on elective knee surgeries.

Nov 21, 2001

Nov 21, 2001

Elderly Connecticut woman dies of inhalational anthrax from unknown source

(CIDRAP News) – The nation's fifth recent death due to inhalational anthrax—that of a 94-year-old Connecticut woman—was announced today as public health officials were explaining that they don't know how the patient contracted anthrax but don't think it was from a naturally occurring source.

Pages

Sort Results

 

Narrow results

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»